Lab901 and Biofortuna to Collaborate on Automated PCR Dx for HLA and Coeliac Disease
News Nov 18, 2009
Lab901 and Biofortuna announced that they will collaborate on the launch of an automated PCR Dx system for detection of certain HLA-related diseases such as coeliac disease.
Lab901 will be optimizing its automated ScreenTape® PCR diagnostics platform for use with Biofortuna’s range of multiplex PCR diagnostics kits for the detection of Coeliac disease, and other HLA related disease such as reactive arthritis, diabetes and drug hypersensitivity.
Lab901’s automated ScreenTape PCR diagnostics platform includes an instrument, pre-packed consumables and analysis software that automatically interprets results, simplifying and speeding up gel electrophoresis.
“We are delighted that Biofortuna have chosen to optimize kits for use on the increasingly popular ScreenTape platform”, commented Richard Rowling, Lab901’s Sales & Marketing Director. “ScreenTape has won acceptance globally for the automated detection, analysis and interpretation of highly multiplexed PCR diagnostic tests and we feel the addition of new content from Biofortuna will help both companies grow sales rapidly”, he added.
Financial terms were not disclosed.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.